Treatment of Dysplasia in Barrett Esophagus
Barrett esophagus is recognized as a risk factor for the development of dysplasia and adenocarcinoma of the esophagus. Cancer is usually diagnosed at an advanced stage with a 5-year survival rate of 15%. Most of these patients present de novo and are not part of a surveillance program. Endoscopic sc...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Society of Gastrointestinal Endoscopy
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928493/ |